» Articles » PMID: 8835672

Elevated Serum Progesterone Values at the Time of Ovulation Induction in Luteal Leuprolide Acetate-down-regulated GIFT Cycles Are Associated with Decreased Clinical Pregnancy Rates

Overview
Publisher Springer
Date 1996 Jul 1
PMID 8835672
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: The effects of premature luteinization of ovarian follicles as detected by elevated progesterone values on the day of human chorionic gonadotropin induction of ovulation were evaluated in 38 consecutive gamete intrafallopian transfer (GIFT) retrieval cycles.

Materials And Methods: All patients received leuprolide acetate beginning in the midluteal phase of their prior menstrual cycle, followed by gonadotropin stimulation of folliculogenesis. At least four oocytes were transferred in each cycle.

Results: No significant differences in gonadotropin dosage, total number of days of gonadotropins, age, number of prior pregnancies, years of infertility since last pregnancy, total number of eggs retrieved, mature residual oocytes, fertilization of mature residual oocytes, or primary etiology of infertility were observed between groups; however, estradiol concentrations were significantly higher in the group with elevated progesterone values (2573 +/- 216 pg/ml) compared to the lower progesterone group (1925 +/- 202 pg/ml, P = 0.035) and the total number of oocytes transferred was greater in the high progesterone group (7.5 +/- 0.5) vs the low progesterone group (6.3 +/- 0.3, P < 0.038). P4 concentrations < or = 0.8 ng/ml were associated with significantly higher pregnancy rates (11/19; 57.9%) compared to progesterone concentrations > 0.8 ng/ml (5/19, 26.3%; P = 0.050).

Conclusions: Premature luteinization may occur in luteal leuprolide acetate-down-regulated patients and progesterone values > 0.8 ng/ml are associated with significantly lower pregnancy rates in GIFT cycles.

Citing Articles

Does elevated serum progesterone on the day of human chorionic gonadotropin administration decrease live birth rates?.

Humm K, Ibrahim Y, Dodge L, Hacker M, Thornton K, Penzias A J Reprod Health Med. 2024; 2(Suppl 2):S15-S18.

PMID: 39723888 PMC: 5987253. DOI: 10.1016/j.jrhm.2016.11.008.


The curious case of premature luteinization.

Kaponis A, Chronopoulou E, Decavalas G J Assist Reprod Genet. 2018; 35(10):1723-1740.

PMID: 30051348 PMC: 6150889. DOI: 10.1007/s10815-018-1264-8.

References
1.
Fleming R, Coutts J . Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril. 1986; 45(2):226-30. DOI: 10.1016/s0015-0282(16)49159-4. View

2.
Cedars M, Surey E, Hamilton F, Lapolt P, Meldrum D . Leuprolide acetate lowers circulating bioactive luteinizing hormone and testosterone concentrations during ovarian stimulation for oocyte retrieval. Fertil Steril. 1990; 53(4):627-31. DOI: 10.1016/s0015-0282(16)53454-2. View

3.
Serafini P, Stone B, Kerin J, Batzofin J, Quinn P, Marrs R . An alternate approach to controlled ovarian hyperstimulation in "poor responders": pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril. 1988; 49(1):90-5. DOI: 10.1016/s0015-0282(16)59655-1. View

4.
Hofmann G, Bentzien F, Bergh P, Garrisi G, Williams M, Guzman I . Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil Steril. 1993; 60(4):675-9. DOI: 10.1016/s0015-0282(16)56221-9. View

5.
Dandekar P, Quigley M . Laboratory setup for human in vitro fertilization. Fertil Steril. 1984; 42(1):1-12. DOI: 10.1016/s0015-0282(16)47949-5. View